HAVA · Harvard Ave Acquisition Corp
$10.26
+0.00 (+0.00%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 29, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company has a related party receivable of $770,645 and working capital of $225,634. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited financial statements are issued. There is no assurance that the Company's plans to consummate a Business Combination will be successful or successful within the required period. The unaudited financial statements do not include any adjustments that might result from the Company's inability to consummate the Business Combination to continue as a going concern.”View the 10-Q filed Jul 29, 2026
Market Cap
$212.31M
Shares
20.69M
Volume · Oct 20
105.08K
Avg daily vol (3M)
108.58K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.25
Open$10.24
Day$10.24–10.26
Available close range$9.88–10.26
Avg vol 30d112K
Short int44 · 0.0% float · 1.0d
Short vol38%
DataDec 2025–Oct 2026
Filing10-Q · Jul 29
The closing range uses available history since Dec 15, 2025; less than a full year is stored.
Up next
filed Jul 29, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
$2.99M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
70.9
Trailing earnings · reciprocal yield 1.4%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+1%
above
RSI (14)
74
overbought
MACD trend
Negative
52-week position
97%
near high
Momentum
relative strength
1-month return
+1%
trailing
YTD return
+3%
this year
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-4% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -24.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
43 holders — 13F breadth
Squeeze score
25
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
2%
annualized · 1-yr
Max drawdown
−1%
past year
ATR
0.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+1%
Bullish
RSI (14)
74
Bearish
MACD trend
Negative
Bearish
52-week position
97%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-4% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -24.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
43 holders — 13F breadth
Price context
position in its available closing range
Range low $10
Now $10 · 97%
Range high $10
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HAVA
this stock
Harvard Ave Acquisition Corp
|
$212.31M | +3.2% | — | — | 0.0% |
|
VYLR
Vylor Inc.
|
$48.31B | — | — | — | — |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$648.15M | +2.9% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$603.18M | +2.9% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HAVA | +0.1% | +0.7% | — | +0.1% | +3.2% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | +1.3% | +1.3% | — | -0.7% | -9.6% |
Key facts
CIK
2042460
CUSIP
G4330A103